封面
市场调查报告书
商品编码
1417543

Olanzapine市场报告:2030 年趋势、预测与竞争分析

Olanzapine Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

Olanzapine趋势和预测

预计到 2030 年,全球Olanzapine市场预计将达到 19 亿美元,2024 年至 2030 年复合年增长率为 2.1%。该市场的主要驱动因素是双相情感障碍治疗的增加、神经系统疾病盛行率的上升以及政府对医疗保健行业基础设施发展的资助增加。全球Olanzapine市场的未来看起来充满希望,双极性情感障碍和思觉失调症市场充满机会。

Olanzapine市场洞察

Lucintel 认为,在预测期内,口服药物将继续成为较大的细分市场,因为它们具有非侵入性、患者依从性高、易于使用且不需要特殊的无菌条件等广泛使用,我预计它将继续下去。

由于北美思觉失调症盛行率不断上升,对Olanzapine製剂的需求不断增加,在预测期内北美仍将是最大的地区。

常问问题

Q1.市场规模有多大?

A1. 到2030年,Olanzapine的全球市场预计将达到19亿美元。

Q2.市场成长预测如何?

A2. 2024年至2030年,Olanzapine的全球市场预计将以2.1%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些?

A3. 该市场的主要驱动力是双相情感障碍治疗的增加、神经系统疾病盛行率的上升以及政府对医疗保健行业基础设施发展的资助增加。

Q4.市场的主要细分市场是什么?

A4. 由于双极性情感障碍和思觉失调症市场的机会,全球Olanzapine市场的未来充满希望。

Q5.市场上主要企业有哪些?

A5. 生产Olanzapine的主要企业如下。

  • Dr ready's laboratory
  • Watson pharmaceuticals
  • Lilly
  • Hamson pharmaceuticals
  • Sun pharmaceuticals
  • Sandoz pharmaceuticals
  • Torrent pharmaceuticals

Q6.未来最大的细分市场是什么?

A6.Lucintel 预计口服药物将占据更大的份额,我们预测它将继续成为一个细分市场。

Q7. 预计未来五年哪个地区将成为最大的市场?

A7. 由于该地区思觉失调症盛行率不断上升,对Olanzapine治疗药物的需求增加,因此在预测期内,北美仍是最大的地区。

Q8. 可以客製化报告吗?

A8. 是的,Lucintel 提供 10% 的客製化服务,无需额外付费。

目录

第一章执行摘要

第二章全球Olanzapine市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球Olanzapine市场趋势(2018-2023)与预测(2024-2030)
  • 按给药途径分類的全球Olanzapine市场
    • 口服
    • 胃肠外的
  • 全球Olanzapine市场应用
    • 躁郁症
    • 思觉失调症
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球Olanzapine市场区域分布
  • 北美Olanzapine市场
  • 欧洲Olanzapine市场
  • 亚太地区奥氮Olanzapine市场
  • 其他地区Olanzapine市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按途径的全球Olanzapine市场成长机会
    • 全球Olanzapine市场成长机会(按应用)
    • 全球Olanzapine市场按地区成长机会
  • 全球Olanzapine市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球Olanzapine市场产能扩张
    • 全球Olanzapine市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • Dr ready's laboratory
  • Watson pharmaceuticals
  • Lilly
  • Hamson pharmaceuticals
  • Sun pharmaceuticals
  • Sandoz pharmaceuticals
  • Torrent pharmaceuticals
简介目录

Olanzapine Trends and Forecast

The future of the global olanzapine market looks promising with opportunities in the bipolar disorder and schizophrenia markets. The global olanzapine market is expected to reach an estimated $1.9 billion by 2030 with a CAGR of 2.1% from 2024 to 2030. The major drivers for this market are the increasing use of bipolar therapy, rise in the prevalence of neurological conditions, and growth in government funding for infrastructure upgrades in the healthcare industry.

A more than 150-page report is developed to help in your business decisions.

Olanzapine by Segment

The study includes a forecast for the global olanzapine by route of administration, application, and region.

Olanzapine Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral
  • Parenteral

Olanzapine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Bipolar Disorder
  • Schizophrenia
  • Others

Olanzapine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Olanzapine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies olanzapine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the olanzapine companies profiled in this report include-

  • Dr ready's laboratory
  • Watson pharmaceuticals
  • Lilly
  • Hamson pharmaceuticals
  • Sun pharmaceuticals
  • Sandoz pharmaceuticals
  • Torrent pharmaceuticals

Olanzapine Market Insights

Lucintel forecasts that oral will remain the larger segment over the forecast period because the oral medications are widely used as they are noninvasive, have high patient compliance, are easy to use, and do not require any special sterile conditions.

North America will remain the largest region over the forecast period due to the increase in demand for olanzapine medications owing to the growth in the prevalence of schizophrenia in this region.

Features of the Global Olanzapine Market

Market Size Estimates: Olanzapine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Olanzapine market size by route of administration, application, and region in terms of value ($B).

Regional Analysis: Olanzapine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different route of administration, application, and regions for the olanzapine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the olanzapine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the olanzapine market size?

Answer: The global olanzapine market is expected to reach an estimated $1.9 billion by 2030.

Q2. What is the growth forecast for olanzapine market?

Answer: The global olanzapine market is expected to grow with a CAGR of 2.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the olanzapine market?

Answer: The major drivers for this market are the increasing use of bipolar therapy, rise in the prevalence of neurological conditions, and growth in government funding for infrastructure upgrades in the healthcare industry.

Q4. What are the major segments for olanzapine market?

Answer: The future of the global olanzapine market looks promising with opportunities in the bipolar disorder and schizophrenia markets.

Q5. Who are the key olanzapine market companies?

Answer: Some of the key olanzapine companies are as follows.

  • Dr ready's laboratory
  • Watson pharmaceuticals
  • Lilly
  • Hamson pharmaceuticals
  • Sun pharmaceuticals
  • Sandoz pharmaceuticals
  • Torrent pharmaceuticals

Q6. Which olanzapine market segment will be the largest in future?

Answer: Lucintel forecasts that oral will remain the larger segment over the forecast period because the oral medications are widely used as they are noninvasive, have high patient compliance, are easy to use, and do not require any special sterile conditions.

Q7. In olanzapine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the increase in demand for olanzapine medications owing to the growth in the prevalence of schizophrenia in this region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the olanzapine market by route of administration (oral and parenteral), application (bipolar disorder, schizophrenia, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Olanzapine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Olanzapine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Olanzapine Market by Route of Administration
    • 3.3.1: Oral
    • 3.3.2: Parenteral
  • 3.4: Global Olanzapine Market by Application
    • 3.4.1: Bipolar disorder
    • 3.4.2: Schizophrenia
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Olanzapine Market by Region
  • 4.2: North American Olanzapine Market
    • 4.2.2: North American Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others
  • 4.3: European Olanzapine Market
    • 4.3.1: European Olanzapine Market by Route of Administration: Oral and Parenteral
    • 4.3.2: European Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others
  • 4.4: APAC Olanzapine Market
    • 4.4.1: APAC Olanzapine Market by Route of Administration: Oral and Parenteral
    • 4.4.2: APAC Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others
  • 4.5: ROW Olanzapine Market
    • 4.5.1: ROW Olanzapine Market by Route of Administration: Oral and Parenteral
    • 4.5.2: ROW Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Olanzapine Market by Route of Administration
    • 6.1.2: Growth Opportunities for the Global Olanzapine Market by Application
    • 6.1.3: Growth Opportunities for the Global Olanzapine Market by Region
  • 6.2: Emerging Trends in the Global Olanzapine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Olanzapine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Olanzapine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Dr ready's laboratory
  • 7.2: Watson pharmaceuticals
  • 7.3: Lilly
  • 7.4: Hamson pharmaceuticals
  • 7.5: Sun pharmaceuticals
  • 7.6: Sandoz pharmaceuticals
  • 7.7: Torrent pharmaceuticals